|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20799992 |
|
NCBI chrNW_004936619:597,970...618,564
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21041608 |
|
NCBI chrNW_004936621:620,163...639,115
|
|
G |
Camk2b |
calcium/calmodulin dependent protein kinase II beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17603807 |
|
NCBI chrNW_004936478:19,183,493...19,278,457
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19386276 |
|
NCBI chrNW_004936489:4,616,839...4,887,179
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20211215 |
|
NCBI chrNW_004936529:3,042,220...3,053,670
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15729709 |
|
NCBI chrNW_004936599:2,197,681...2,200,642
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19747927 |
|
NCBI chrNW_004936480:5,042,531...5,047,157
|
|
G |
Htr6 |
5-hydroxytryptamine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20705401 |
|
NCBI chrNW_004936474:5,848,719...5,858,520
|
|
G |
LOC101958197 |
regulator of G protein signaling 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17318883 |
|
NCBI chrNW_004936541:7,472,195...7,525,220
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17196621 |
|
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19566775 |
|
NCBI chrNW_004936555:2,267,727...2,276,673
|
|
G |
Oprm1 |
opioid receptor mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16402083 |
|
NCBI chrNW_004936489:6,506,207...6,567,136
|
|
G |
Phb |
prohibitin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18504422 |
|
NCBI chrNW_004936490:12,127,065...12,138,870
|
|
G |
Pick1 |
protein interacting with PRKCA 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17606663 |
|
NCBI chrNW_004936492:3,098,196...3,115,921
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12931138 |
|
NCBI chrNW_004936815:359,775...400,690
|
|
G |
Snca |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15542733 |
|
NCBI chrNW_004936685:2,077,017...2,175,298
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16807759 |
|
NCBI chrNW_004936489:11,178,338...11,191,601
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26711020 |
|
NCBI chrNW_004936558:4,362,693...4,387,705
|
|
G |
Foxo4 |
forkhead box O4 |
|
ISO |
protein:increased phosphorylation:small intestine: |
RGD |
PMID:23292333 |
RGD:10402360 |
NCBI chrNW_004936762:495,271...501,278
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24972622 |
RGD:10401897 |
NCBI chrNW_004936792:531,076...579,083
|
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
|
RGD |
PMID:26174132 |
RGD:11534754 |
NCBI chrNW_004936612:1,094,686...1,154,149
|
|
|
G |
Ank3 |
ankyrin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29109170 |
|
NCBI chrNW_004936614:2,664,594...2,976,174
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
|
RGD |
PMID:15007105 |
RGD:12904641 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26074427 |
|
NCBI chrNW_004936533:3,601,270...3,637,128
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
treatment |
ISO |
|
RGD |
PMID:22037411 PMID:23763370 |
RGD:13210751 RGD:13432044 |
NCBI chrNW_004936587:3,406,055...3,806,956
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
mRNA:decreased expression:cerebellum (rat) |
RGD |
PMID:16909201 |
RGD:12904886 |
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
protein:decreased activity:cerebellum (rat) |
RGD |
PMID:16909201 |
RGD:12904886 |
NCBI chrNW_004936483:4,563,995...4,860,231
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25511929 |
|
NCBI chrNW_004936558:5,162,471...5,302,488
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
Protein:increased expression, increased activity:cerebellum (rat) |
RGD |
PMID:12700235 |
RGD:12801493 |
NCBI chrNW_004936735:1,252,414...1,338,318
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29109170 |
|
NCBI chrNW_004936474:10,996,867...11,030,504
|
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
protein:increased activation:neuron, cerebellum |
RGD |
PMID:17109064 |
RGD:2298867 |
NCBI chrNW_004936529:1,000,050...1,045,655
|
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
|
ISO |
|
RGD |
PMID:24814703 |
RGD:10047100 |
NCBI chrNW_004936519:6,831,096...6,873,977
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:22959208 |
RGD:7204702 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:23077050 |
RGD:8551854 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
|
ISO |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:23229539 |
RGD:12904023 |
NCBI chrNW_004936471:36,547,552...36,601,327
|
|